Novel digital therapy for amblyopia demonstrates positive phase 3 results

Luminopia One, an investigational digital therapy that allows patients with amblyopia to watch visually modified TV shows and movies to improve vision, has shown positive results, according to a press release from Luminopia.
The phase 3 multicenter, randomized, controlled pivotal clinical trial, published in Ophthalmology, was designed to test the safety and efficacy of Luminopia One in patients with amblyopia aged 4 to 7 years. The trial included 105 patients, with 51 randomly assigned to the treatment group and 54 to the placebo group.
At 12 weeks, 45 patients in (Read more...)

Full Story →